Clinical, Ultrasonographic, and Roentgenograhic Study in 134 Asymptomatic Gallstone Carriers is Oral Ursodeoxycholic Acid Treatment Worthwhile?

References

• Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Prevalence of gallstone disease in an Italian adult female population. Am J Epidemiol 1984; 119: 796–805
   PubMed Web of Science ®Google Scholar
• Progetto Distretto Sezze Controllo Comunitario (DISCO), the National Research Council and the Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Epidemiology of gallstone disease in Italy: comparison between a rural and urban female population. Ital J Gastroenterol 1987; 19: 129–33
   Google Scholar
• Barbara L, Sama C, Morselli Labate A M, et al. A population study on the prevalence of gallstone disease. The Sirmione study. Hepatology 1987; 7: 913–7
   PubMed Web of Science ®Google Scholar
• Glambek I, Kvaale G, Arnesjö B, Søreide O. Prevalence of gallstones in a Norwegian population. Scand J Gastroenterol 1987; 22: 1089–94
   PubMed Web of Science ®Google Scholar
• Maurer K R, Everhart J E, Ezzati T M, et al. Prevalence of gallstone disease in Hispanic populations in the United States. Gastroenterology 1989; 96: 487–92
   PubMed Web of Science ®Google Scholar
• Heaton K W, Braddon F EM, Mountford R A, Hughes A O, Emmett PM. Symptomatic and silent gallstones in the community. Gut 1991; 32: 316–20
   PubMed Web of Science ®Google Scholar
• The MICOL Group. Prevalence of gallstone disease in 18 Italian population samples: first results from the MICOL study. Recent advances in the epidemiology and prevention of gallstone disease, L Capocaccia, et al. Kluwer Academic Publishers, Dordrecht 1991; 37–44
   Google Scholar
• Schoenfield L J, Carulli N, Dowling R H, Sama C, Wolpers C. Asymptomatic gallstones: definition and treatment. Gastroenterol Int 1989; 2: 25–9
   Google Scholar
• Gracie W A, Ransohoff DF. The natural history of gallstones. The 'innocent' gallstone is not a myth. N Engl J Med 1982; 307: 798–800
   PubMed Web of Science ®Google Scholar
• McSherry C K, Ferstenberg H, Calhoum W F, et al. The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg 1985; 202: 59–63
   PubMed Web of Science ®Google Scholar
• Attili A F, Capri R, Repice A M, Maselli S. The GREPCO Group. The natural history of gallstones: the GREPCO experience. Recent advances in the epidemiology and prevention of gallstone disease, L Capocaccia, et al. Kluwer Academic Publishers, Dordrecht 1991; 47–50
   Google Scholar
• Sama C, Barbara L, Festi D, . Natural history of gallstone disease: the Sirmione study. Recent advances in the epidemiology and prevention of gallstone disease, L Capocaccia, et al. Kluwer Academic Publishers, Dordrecht 1991; 51–5
   Google Scholar
• Paumgartner G, Carr-Locke D L, Roda E, Thistle JL. Biliary stones: non-surgical therapeutic approach. Gastroenterol Int 1988; 1: 17–24
   Google Scholar
• Mok H YI, Druffel E RM, Rampone WM. Chronology of cholelithiasis. Dating gallstones from atmospheric radiocarbon produced by nuclear bomb explosions. N Engl J Med 1986; 314: 314–1075
   Google Scholar
• Erlinger S, Le Go A, Husson J M, Fevery J. Franco-Belgian Cooperative Study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid. Hepatology 1984; 4: 308–14
   PubMed Web of Science ®Google Scholar
• Gleeson D, Ruppin D C, Saunders A, Murphy G M, Dowling RH. Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent stones. Q J Med 1990; 76: 711–29
   PubMedGoogle Scholar
• Lirussi F, Iemmolo R M, Piccoli A, et al. Evaluation of prognostic factors of medical dissolution of cholesterol gallstones using Cox's multivariate regression model. Curr Ther Res 1988; 43: 128–33
   Google Scholar
• Jorgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol 1987; 126: 912–21
   PubMed Web of Science ®Google Scholar
• Nomura H, Kashiwagi S, Hayashi J, et al. Prevalence of gallstone disease in a general population of Okinawa, Japan. Am J Epidemiol 1988; 128: 598–605
   PubMed Web of Science ®Google Scholar
• Wolpers C. Veränderungen an 'stillen' Gallenblasensteinen. Röntgendiagnostiche und symptomatologische Beobachtungen über 30 Jahre. Dtsch Med Wochenschr 1986; 111: 1186–91
   PubMedGoogle Scholar
• Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Radiologic appearance of gallstones and its relationship with biliary symptoms and awareness of having gallstones. Observations during epidemiological studies. Dig Dis Sci 1987; 32: 349–53
   PubMedGoogle Scholar
• Podda M, Zuin M, Battezzati P M, et al. Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone. Gastroenterology 1989; 96: 222–9
   PubMed Web of Science ®Google Scholar
• Thistle J L, Cleary P A, Lachin J M, et al. Steering Committee and the National Cooperative Gallstone Study Group. The natural history of cholelithiasis. The National Cooperative Gallstone Study. Ann Intern Med 1984; 101: 171–5
   PubMed Web of Science ®Google Scholar
• Maudgal D P, Kupfer R M, Zentler-Munro P L, Northfield TC. Postprandial gallbladder emptying in patients with gallstones. Br Med J 1980; 280: 141–3
   PubMedGoogle Scholar
• Van Berge Henegouwen G P, Hofmann AF. Nocturnal gallbladder storage and emptying in gallstone patients and healthy subjects. Gastroenterology 1978; 75: 879–85
   PubMed Web of Science ®Google Scholar
• Mok H YI, Von Bergman K, Grundy SM. Kinetics of the entero-hepatic circulation during fasting: biliary lipid secretion and gallbladder storage. Gastroenterology 1980; 78: 1023–33
   PubMedGoogle Scholar
• Fisher R S, Stelzer F, Rock E, Malmud LS. Abnormal gallbladder emptying in patients with gallstones. Dig Dis Sci 1982; 27: 1019–24
   PubMed Web of Science ®Google Scholar
• Forgacs I C, Maisey M N, Murphy G M, Dowling RH. Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying. Gastroenterology 1984; 87: 299–307
   PubMedGoogle Scholar
• Pomeranz I S, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985; 88: 787–91
   PubMed Web of Science ®Google Scholar
• Festi D, Frabboni R, Bazzoli F, et al. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 1990; 98: 1779–85
   Google Scholar
• Spengler U, Sackman M, Sauerbruch T, Holl J, Paumgartner G. Gallbladder motility before and after extracorporeal shock-wave lithotripsy. Gastroenterology 1989; 96: 860–3
   PubMedGoogle Scholar
• Lirussi F, Nassuato G, Passera D, . Aging and gallstone disease. Recent advances in the epidemiology and prevention of gallstone disease, L Capocaccia, et al. Kluwer Academic Publishers, Dordrecht 1991; 37–44
   Google Scholar
• Roda E, Bazzoli F, Morselli Labate A M, et al. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology 1982; 6: 804–10
   Google Scholar
• Walters J RF, Hood K A, Gleeson D, et al. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pre-treatment computed tomography of the gallbladder improves gallstone dissolution efficacy. Gut 1992; 33: 375–80
   PubMedGoogle Scholar
• Rajagopal S U, Bills P, Keightley A, et al. Predictive value of computed tomography (CT) scanning of the gallbladder in determining gallstone type. Gut 1988; 29: A–1487
   Google Scholar
• Ramlow A, Staritz M, Wosiewitz U, et al. Analysis of radiolucent gallstones by computed tomography for in vivo estimation of stone components. J Clin Invest 1990; 20: 475–8
   Google Scholar
• Ell C, Schneider H T, Benninger J, et al. Significance of computed tomography for shock-wave therapy of radiolucent gallbladder stones. Gastroenterology 1991; 101: 1409–16
   PubMedGoogle Scholar
• Schoenfield L J, Lachin J M, Committee The Steering, et al. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones. The National Cooperative Gallstone Study. A controlled trial of efficacy and safety. Ann Intern Med 1981; 95: 257–82
   PubMed Web of Science ®Google Scholar
• Fisher M M, Roberts E A, Rosen I E, et al. The Sunnybrook Gallstone Study: a double blind controlled trial of chenodeoxycholic acid for gallstone dissolution. Hepatology 1985; 5: 5–102
   Google Scholar
• Maton P N, Iser J H, Reuben A, et al. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Medicine 1982; 61: 86–97
   PubMed Web of Science ®Google Scholar